Avinash Bajaj | Avinashlab

Key Publications

Yadav P, Rana K, Chakraborty R, Khan A, Mehta D, Jain D, Aggarwal B, Jha S, Dasgupta U, Bajaj A*. Engineered Nanomicelles Targeting the Proliferation and Angiogenesis Inhibit the Tumour Progression by Impairing the Synthesis of Ceramide-1-Phosphate. Nanoscale. 2024, 16, 10350-10365.
Yadav P, Rana K, Nardini V, Khan A, Pani T, Kar A, Jain D, Chakraborty R, Singh R, Jha SK, Mehta D, Sharma H, Sharma RD, Deo SVS, Sengupta S, Patil VS, Faccioli LH, Dasgupta U, Bajaj A*. Engineered Nanomicelles inhibit the tumour progression via abrogating the prostaglandin-mediated immunosuppression. J Control Release. 2024, 368, 548-565.
Safwan SM, Kumar N, Mehta D, Singh M, Saini V, Pandey N, Khatol S, Batheja S, Singh J, Walia P, Bajaj A*. "Xanthone Derivatives can Enhance the Therapeutic Potential of Neomycin against Polymicrobial Gram-negative Bacterial Infections". ACS Infect. Diseas. 2024, 10, 2, 527-540.
Arora A, Singh M, Saini Va, Mehta D, Safwan SM, Pandey N, Verma V, Bajaj A*. "Cholic Acid-derived Gemini Amphiphile can Eradicate Interkingdom Polymicrobial Biofilms and Wound Infections". ACS Infect. Diseas. 2024, 10, 1, 138-154.
Kar A, Jain D, Kumar S, Rajput K, Pal S, Rana K, Kar R, Jha SK, Medatwal N, Yavvari PS, Mehta D, Pradhan MK, Pandey N, Srivastava A, Mukhopadhyay A, Agarwal U, Sengupta S, Patil VS, Bajaj A*, and Dasgupta U. "A Localized Hydrogel-mediated Chemotherapy Causes Immunogenic Cell Death via Activation of Ceramide-mediated Unfolded Protein Response". Sci. Adv. 2023, 9.

NEWS

Detecting tuberculosis outside lungs

A team led by Avinash Bajaj develops a fluorescent probe to detect mycobacteria from human tissue samples.

Nanomicelles: using nanoparticles for cancer treatment.

Dr. Avinash Bajaj and team have developed nanomicelles which serve as efficient systems through which the drugs can be delivered. This drug delivery system predominantly targets only the cancerous cells, but not the normal healthy cells.

Researchers combat tumour growth by packing three drugs into a single biomaterial.

Avinash Bajaj and his team at Regional Centre for Biotechnology, Faridabad, experts in the field of biomaterials and nanomedicine, have designed an efficient drug delivery system that packs three different drugs that counter tumour growth.

Devashish Mehta and Poonam Yadav got the best poster prize at the 29th CRSI-National Symposium in Chemistry held at IISER Mohali, India from July 7-9, 2022.

Contact Us!

Regional Centre for Biotechnology (RCB) is an academic institution established by the Department of Biotechnology, Govt. of India with regional and global partnerships synergizing with the programmes of UNESCO as a Category II Centre. The primary focus of RCB is to provide world class education, training and conduct innovative research at the interface of multiple disciplines to create high quality human resource in disciplinary and interdisciplinary areas of biotechnology in a globally competitive research milieu. In 2016, RCB was recognised as an Institution of National Importance by the Parliament of India.

For Inquiry Call us at: 0129-2848800

3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad Rd, Faridabad, Haryana 121001.